Clinical Scorecard: Sharper Imaging, Smarter Tools: Inside the MonacoPro
At a Glance
| Category | Detail |
|---|---|
| Condition | Retinal and choroidal diseases, glaucoma, diabetic retinopathy, systemic diseases affecting the retina |
| Key Mechanisms | Integration of 200° ultrawidefield (UWF) scanning laser ophthalmoscopy and spectral-domain OCT imaging with intelligent analysis tools and a large reference database |
| Target Population | Patients requiring retinal evaluation including those with glaucoma, diabetes, hypertension, neurologic disorders, children, and patients with mobility challenges |
| Care Setting | Primary eye care, large population screening, ophthalmology clinics, telemedicine programs |
Key Highlights
- MonacoPro captures up to 80% of the retina with 200° UWF imaging and combines it with high-resolution OCT to detect 29.4% more macular pathology than UWF alone.
- AreaAssist tool automates lesion measurement and sensitivity adjustment, improving workflow and diagnostic confidence.
- Multimodal imaging (color, red-free, choroidal views, green autofluorescence, and OCT) enables comprehensive retinal assessment without pupil dilation.
Guideline-Based Recommendations
Diagnosis
- Use combined UWF and OCT imaging to enhance detection of peripheral and macular retinal pathology.
- Employ multimodal imaging including autofluorescence and spectral-domain OCT for detailed assessment of optic nerve, macula, and lesions.
- Leverage the large reference database for comparison with age-matched normals to identify potential pathology.
Management
- Utilize AreaAssist for lesion mapping and longitudinal comparison to monitor disease progression.
- Apply OptosAdvance software for accurate measurement and historical overlay in chronic conditions like glaucoma and diabetes.
- Use imaging data to limit unnecessary referrals and expedite treatment decisions.
Monitoring & Follow-up
- Perform serial imaging to track changes in retinal lesions and glaucoma-related structural changes.
- Use multimodal imaging to assess treatment effectiveness and disease progression.
- Capture images quickly without dilation to facilitate frequent monitoring.
Risks
- No specific risks detailed; device designed for safe use across diverse patient populations including those with limited mobility or photophobia.
Patient & Prescribing Data
Patients undergoing retinal evaluation including those with chronic systemic diseases affecting the eye and patients with mobility or cooperation challenges
MonacoPro imaging supports early detection and monitoring of retinal diseases, enabling timely intervention and reducing delays in care.
Clinical Best Practices
- Incorporate MonacoPro imaging as a baseline for future OCT scans to enhance longitudinal assessment.
- Use the AreaAssist tool to automate lesion delineation and improve diagnostic accuracy.
- Perform imaging without pupil dilation to increase patient comfort and throughput.
- Leverage the device’s ADA-compliant design and adjustable features to accommodate diverse patient needs.
- Utilize the extensive reference database to contextualize findings and guide clinical decisions.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.